Statera Biopharma Pink Sheet Forecast - 4 Period Moving Average
| STAB Stock | USD 0.0001 0.0002 66.67% |
The 4 Period Moving Average forecasted value of Statera Biopharma on the next trading day is expected to be 0.0002 with a mean absolute deviation of 0.000037 and the sum of the absolute errors of 0. Statera Pink Sheet Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Statera Biopharma stock prices and determine the direction of Statera Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Statera Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Statera |
Statera Biopharma 4 Period Moving Average Price Forecast For the 30th of December
Given 90 days horizon, the 4 Period Moving Average forecasted value of Statera Biopharma on the next trading day is expected to be 0.0002 with a mean absolute deviation of 0.000037, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Statera Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Statera Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Statera Biopharma Pink Sheet Forecast Pattern
| Backtest Statera Biopharma | Statera Biopharma Price Prediction | Buy or Sell Advice |
Statera Biopharma Forecasted Value
In the context of forecasting Statera Biopharma's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Statera Biopharma's downside and upside margins for the forecasting period are 0.000001 and 35.40, respectively. We have considered Statera Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Statera Biopharma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Statera Biopharma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 91.1891 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.2712 |
| SAE | Sum of the absolute errors | 0.0021 |
Predictive Modules for Statera Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Statera Biopharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Statera Biopharma
For every potential investor in Statera, whether a beginner or expert, Statera Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Statera Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Statera. Basic forecasting techniques help filter out the noise by identifying Statera Biopharma's price trends.Statera Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Statera Biopharma pink sheet to make a market-neutral strategy. Peer analysis of Statera Biopharma could also be used in its relative valuation, which is a method of valuing Statera Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Statera Biopharma Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Statera Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Statera Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Statera Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Statera Biopharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Statera Biopharma shares will generate the highest return on investment. By undertsting and applying Statera Biopharma pink sheet market strength indicators, traders can identify Statera Biopharma entry and exit signals to maximize returns.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.33 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | (0.0002) | |||
| Relative Strength Index | 46.5 |
Statera Biopharma Risk Indicators
The analysis of Statera Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Statera Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting statera pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 19.46 | |||
| Semi Deviation | 17.4 | |||
| Standard Deviation | 35.4 | |||
| Variance | 1252.92 | |||
| Downside Variance | 3388.89 | |||
| Semi Variance | 302.69 | |||
| Expected Short fall | (92.86) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Statera Pink Sheet
Statera Biopharma financial ratios help investors to determine whether Statera Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Statera with respect to the benefits of owning Statera Biopharma security.